Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with heart failure: Comparison with enalapril

被引：0
|
作者：
Abassi, ZA
Zeid, S
Yahia, A
Winaver, J
Hoffman, A
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Dept Physiol & Biophys, Haifa, Israel
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
omapatrilat; cardiac hypertrophy; renal function;
D O I：
10.1016/S0895-7061(03)00288-7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P123
引用
收藏
页码：84A / 84A
页数：1
相关论文
共 50 条
  • [1] Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure
    Abassi, ZA
    Yahia, A
    Zeid, S
    Karram, T
    Golomb, E
    Winaver, J
    Hoffman, A
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (02): : H722 - H728
  • [2] Effects of omapatrilat, a vasopeptidase inhibitor, on renal function and cardiac hypertrophy in rats with experimental heart failure.
    Abassi, Z
    Yahia, A
    Zeid, S
    Hayek, T
    Winaver, J
    Hoffman, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 514A - 514A
  • [3] Vasopeptidase inhibitor, omapatrilat, improved cardiac function and remodelling in rats with chronic heart failure
    Maki, T
    Nasa, Y
    Tanonaka, K
    Takeo, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 78P - 78P
  • [4] The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
    McClean, DR
    Ikram, H
    Garlick, AH
    Richards, AM
    Nicholls, MG
    Crozier, IG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) : 479 - 486
  • [5] A comparison of the vasopeptidase inhibitor omapatrilat vs lisinopril in subjects with heart failure
    Kostis, J
    Rouleau, JL
    Pfeffer, MA
    Rousseau, MF
    Ikram, H
    Komajda, M
    EUROPEAN HEART JOURNAL, 2000, 21 : 344 - 344
  • [6] Beneficial effects of the vasopeptidase inhibitor omapatrilat on neurogenic volume retention in rats with experimental congestive heart failure (CHF)
    Klanke, B
    Karl, HF
    Ditting, T
    Schmieder, RE
    Veelken, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 512A - 512A
  • [7] Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats
    Wenzel, UO
    Wolf, G
    Jacob, I
    Schwegler, C
    Qasqas, A
    Amann, K
    Helmchen, U
    Stahl, RAK
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) : 2005 - 2013
  • [8] Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction
    Blais, C
    Lapointe, N
    Rouleau, JL
    Clément, R
    Gervais, N
    Geadah, D
    Adam, A
    PEPTIDES, 2001, 22 (06) : 953 - 962
  • [9] The antihypertensive and antihypertrophic effects of the vasopeptidase inhibitor omapatrilat in spontaneously hypertensive rats
    Wei, CM
    Dong, YF
    Zhou, H
    Shaffer, E
    Liao, WC
    McLaughlin, JS
    FASEB JOURNAL, 2001, 15 (04): : A466 - A466
  • [10] Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease
    Dudman, N
    Hunt, D
    MacMahon, S
    Neal, B
    Richards, M
    Simes, J
    Tonkin, A
    Wilcken, D
    Murphy, J
    Cleverly, Y
    Keech, A
    Ohkubo, T
    Brnabic, A
    Tonkin, A
    Bos, K
    Bartram, H
    Bennett, D
    Broad, J
    Douglas, D
    Fisher, S
    Gray, B
    Milne, A
    McCulloch, A
    Ng, C
    Pledger, M
    Pryor, A
    Santos, A
    Slater, A
    Yiu, K
    Woodward, M
    Burrell, L
    Brown, L
    Hamer, A
    Roberts, L
    Jeffery, I
    Taverner, P
    Kam, A
    Aylward, P
    Wollaston, F
    Whitehead, A
    Lane, G
    Tulloch, G
    Forrest, N
    Garrett, J
    Aroney, G
    Hicks, P
    Silberberg, J
    Gordon, A
    Holliday, J
    Hicks, L
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2002, 3 (04) : 270 - 276
12345